{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T01:00:37Z","timestamp":1768438837623,"version":"3.49.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Science and Technology Development Fund, Macau SAR","award":["0048\/2023\/AFJ and 0164\/2023\/RIA3"],"award-info":[{"award-number":["0048\/2023\/AFJ and 0164\/2023\/RIA3"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Bronchiectasis is a complex and heterogeneous disease with various etiologies and clinical manifestations. While Western medicine (WM) primarily focuses on infection control, symptom management, and airway clearance techniques, traditional Chinese medicine (TCM) adopts a holistic strategy aimed at systemic regulation and immune modulation through herbal formulae and acupuncture. The integration of TCM and WM offers a comprehensive therapeutic framework that targets both clinical manifestations and the underlying pathophysiology. This review systematically outlines current WM treatment strategies, such as antibiotic therapy, anti-inflammatory drugs, and surgical interventions. The TCM treatment principles, including individualized syndrome differentiation and treatment, specific TCM formulae, and acupuncture therapies, are detailed. This study further synthesizes clinical evidence demonstrating that integrated TCM-WM therapy not only significantly alleviates symptoms and improves lung function but also enhances immune regulation and quality of life. This combined strategy not only improves clinical outcomes but also enhances patients\u2019 quality of life, which provides a more personalized and multidimensional paradigm to manage bronchiectasis. Future research should focus on optimizing integrated protocols, rigorous randomized controlled trials, and exploring novel therapeutic targets to consolidate the evidence base for this synergistic model.<\/jats:p>","DOI":"10.1186\/s13020-026-01324-0","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T07:30:47Z","timestamp":1768375847000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrated traditional Chinese medicine and Western medicine strategies for the treatment of bronchiectasis: a comprehensive review"],"prefix":"10.1186","volume":"21","author":[{"given":"Yue","family":"Ou-Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Xuan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Yang","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Biao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"issue":"1","key":"1324_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-018-0042-3","volume":"4","author":"JD Chalmers","year":"2018","unstructured":"Chalmers JD, Chang AB, Chotirmall SH, Dhar R, McShane PJ. Bronchiectasis. Nat Rev Dis Primers. 2018;4(1):45.","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"1324_CR2","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.rmed.2006.03.012","volume":"100","author":"PT King","year":"2006","unstructured":"King PT, Holdsworth SR, Freezer NJ, Villanueva E, Holmes PW. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100(12):2183\u20139.","journal-title":"Respir Med"},{"issue":"12","key":"1324_CR3","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1164\/rccm.201910-1972OC","volume":"201","author":"Y-h Gao","year":"2020","unstructured":"Gao Y-h, Abo Leyah H, Finch S, Lonergan M, Aliberti S, De Soyza A, et al. Relationship between symptoms, exacerbations, and treatment response in bronchiectasis. American J Respir Crit Care Med. 2020;201(12):1499\u2013507.","journal-title":"American J Respir Crit Care Med"},{"issue":"5","key":"1324_CR4","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41385-020-00370-7","volume":"14","author":"JD Davis","year":"2021","unstructured":"Davis JD, Wypych TP. Cellular and functional heterogeneity of the airway epithelium. Mucosal Immunol. 2021;14(5):978\u201390.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"1324_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.arbres.2022.09.004","volume":"59","author":"B Solarat","year":"2023","unstructured":"Solarat B, Perea L, Faner R, de La Rosa D, Mart\u00ednez-Garc\u00eda M\u00c1, Sibila O. Pathophysiology of chronic bronchial infection in bronchiectasis. Arch Bronconeumol. 2023;59(2):101\u20138.","journal-title":"Arch Bronconeumol"},{"issue":"Suppl 2","key":"1324_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s15010-005-8208-9","volume":"33","author":"M Ulrich","year":"2005","unstructured":"Ulrich M, Berger J, M\u00f6ller J-G, D\u00f6ring G. Moxifloxacin and ciprofloxacin protect human respiratory epithelial cells against Streptococcus pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Haemophilus influenzae in vitro. Infection. 2005;33(Suppl 2):50\u20134.","journal-title":"Infection"},{"issue":"12","key":"1324_CR7","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1099\/mic.0.000393","volume":"162","author":"TE Woo","year":"2016","unstructured":"Woo TE, Duong J, Jervis NM, Rabin HR, Parkins MD, Storey DG. Virulence adaptations of Pseudomonas aeruginosa isolated from patients with non-cystic fibrosis bronchiectasis. Microbiology. 2016;162(12):2126\u201335.","journal-title":"Microbiology"},{"issue":"2","key":"1324_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.arbres.2017.07.015","volume":"54","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2018","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, M\u00e1iz L, Olveira C, Gir\u00f3n RM, de la Rosa D, Blanco M, et al. Normativa sobre la valoraci\u00f3n y el diagn\u00f3stico de las bronquiectasias en el adulto. Arch Bronconeumol. 2018;54(2):79\u201387.","journal-title":"Arch Bronconeumol"},{"key":"1324_CR9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, Aliberti S, Marshall SE, Loebinger MR, et al. European respiratory society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00629-2017.","journal-title":"Eur Respir J"},{"key":"1324_CR10","doi-asserted-by":"crossref","unstructured":"Keir HR, Chalmers JD, editors. Pathophysiology of bronchiectasis. Seminars in respiratory and critical care medicine. 2021. Thieme Medical Publishers, Inc.","DOI":"10.1055\/s-0041-1730891"},{"issue":"8","key":"1324_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1164\/rccm.201301-0059CI","volume":"188","author":"MR Knowles","year":"2013","unstructured":"Knowles MR, Daniels LA, Davis SD, Zariwala MA, Leigh MW. Primary ciliary dyskinesia. Recent advances in diagnostics, genetics, and characterization of clinical disease. Am J Respir Crit Care Med. 2013;188(8):913\u201322.","journal-title":"Am J Respir Crit Care Med"},{"key":"1324_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105267","volume":"162","author":"C Fonseca","year":"2020","unstructured":"Fonseca C, Bicker J, Alves G, Falc\u00e3o A, Fortuna A. Cystic fibrosis: physiopathology and the latest pharmacological treatments. Pharmacol Res. 2020;162:105267.","journal-title":"Pharmacol Res"},{"issue":"6","key":"1324_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/RTI.0000000000000350","volume":"33","author":"TJ Bang","year":"2018","unstructured":"Bang TJ, Richards JC, Olson AL, Groshong SD, Gelfand EW, Lynch DA. Pulmonary manifestations of common variable immunodeficiency. J Thorac Imaging. 2018;33(6):377\u201383.","journal-title":"J Thorac Imaging"},{"key":"1324_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1197361","volume":"14","author":"V Daza-Cajigal","year":"2023","unstructured":"Daza-Cajigal V, Segura-Guerrero M, L\u00f3pez-Cueto M, Robles-Marhuenda A, Camara C, Gerra-Gal\u00e1n T, et al. Clinical manifestations and approach to the management of patients with common variable immunodeficiency and liver disease. Front Immunol. 2023;14:1197361.","journal-title":"Front Immunol"},{"issue":"10","key":"1324_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1080\/17476348.2020.1794827","volume":"14","author":"A Chopra","year":"2020","unstructured":"Chopra A, Avadhani V, Tiwari A, Riemer EC, Sica G, Judson MA. Granulomatous lung disease: clinical aspects. Expert Rev Respir Med. 2020;14(10):1045\u201363.","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"1324_CR16","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1016\/j.athoracsur.2021.05.088","volume":"113","author":"D Shimizu","year":"2022","unstructured":"Shimizu D, Otani S, Sugimoto S, Yamamoto H, Tomioka Y, Shiotani T, et al. Lung transplantation for bronchiectasis due to hyperimmunoglobulin E syndrome. Ann Thorac Surg. 2022;113(4):e251\u20133.","journal-title":"Ann Thorac Surg"},{"issue":"8","key":"1324_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1164\/rccm.202108-1889OC","volume":"205","author":"A Shoemark","year":"2022","unstructured":"Shoemark A, Shteinberg M, De Soyza A, Haworth CS, Richardson H, Gao Y, et al. Characterization of eosinophilic bronchiectasis: a European multicohort study. Am J Respir Crit Care Med. 2022;205(8):894\u2013902.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"1324_CR18","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S2213-2600(24)00176-0","volume":"12","author":"MB Long","year":"2024","unstructured":"Long MB, Chotirmall SH, Shteinberg M, Chalmers JD. Rethinking bronchiectasis as an inflammatory disease. Lancet Respir Med. 2024;12(11):901\u201314.","journal-title":"Lancet Respir Med"},{"key":"1324_CR19","unstructured":"McDonnell M. Role of Gastro-Oesophageal Reflux in the Development and Severity of Bronchiectasis: Newcastle University. 2020."},{"issue":"1","key":"1324_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-024-05149-x","volume":"28","author":"W Fan","year":"2024","unstructured":"Fan W, Gui B, Zhou X, Li L, Chen H. A narrative review on lung injury: mechanisms, biomarkers, and monitoring. Crit Care. 2024;28(1):352.","journal-title":"Crit Care"},{"issue":"2","key":"1324_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1513\/AnnalsATS.201906-427CME","volume":"17","author":"AS Lee","year":"2020","unstructured":"Lee AS, Lee JS, He Z, Ryu JH. Reflux-aspiration in chronic lung disease. Ann Am Thorac Soc. 2020;17(2):155\u201364.","journal-title":"Ann Am Thorac Soc"},{"key":"1324_CR22","doi-asserted-by":"crossref","unstructured":"McDonnell MJ, Hunt EB, Ward C, Pearson JP, O\u2019Toole D, Laffey JG, et al. Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review. ERJ Open Research. 2020. 6 (4).","DOI":"10.1183\/23120541.00190-2019"},{"issue":"1","key":"1324_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ccm.2021.11.005","volume":"43","author":"R Sobala","year":"2022","unstructured":"Sobala R, De Soyza A. Bronchiectasis and chronic obstructive pulmonary disease overlap syndrome. Clin Chest Med. 2022;43(1):61\u201370.","journal-title":"Clin Chest Med"},{"key":"1324_CR24","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0234-2023","author":"E Johnson","year":"2024","unstructured":"Johnson E, Long MB, Chalmers JD. Biomarkers in bronchiectasis. Eur Respir Rev. 2024. https:\/\/doi.org\/10.1183\/16000617.0234-2023.","journal-title":"Eur Respir Rev"},{"issue":"2","key":"1324_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.chom.2016.01.001","volume":"19","author":"M Zanin","year":"2016","unstructured":"Zanin M, Baviskar P, Webster R, Webby R. The interaction between respiratory pathogens and mucus. Cell Host Microbe. 2016;19(2):159\u201368.","journal-title":"Cell Host Microbe"},{"key":"1324_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2213-0802-2-6","volume":"2","author":"BK Rubin","year":"2014","unstructured":"Rubin BK. Secretion properties, clearance, and therapy in airway disease. Transl Respir Med. 2014;2:1\u20137.","journal-title":"Transl Respir Med"},{"issue":"1","key":"1324_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-micro-091014-104209","volume":"69","author":"SJ Siegel","year":"2015","unstructured":"Siegel SJ, Weiser JN. Mechanisms of bacterial colonization of the respiratory tract. Annu Rev Microbiol. 2015;69(1):425\u201344.","journal-title":"Annu Rev Microbiol"},{"issue":"8","key":"1324_CR28","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4155\/tde-2017-0037","volume":"8","author":"SP Newman","year":"2017","unstructured":"Newman SP. Drug delivery to the lungs: challenges and opportunities. Ther Deliv. 2017;8(8):647\u201361.","journal-title":"Ther Deliv"},{"issue":"3","key":"1324_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/resp.13459","volume":"24","author":"K O\u2019Neill","year":"2019","unstructured":"O\u2019Neill K, O\u2019Donnell AE, Bradley JM. Airway clearance, mucoactive therapies and pulmonary rehabilitation in bronchiectasis. Respirology. 2019;24(3):227\u201337.","journal-title":"Respirology"},{"key":"1324_CR30","unstructured":"Adults ECWGotDaToBi. Expert consensus on the diagnosis and treatment of bronchiectasis in adults (2012 edition). CHIN J Crit Care Med (Electronic Edition). 2012. 5 (005):20\u201330."},{"key":"1324_CR31","doi-asserted-by":"crossref","unstructured":"Franks LJ, Walsh JR, Hall K, Morris NR. Measuring airway clearance outcomes in bronchiectasis: a review. European Respiratory Review. 2020. 29 (156).","DOI":"10.1183\/16000617.0161-2019"},{"key":"1324_CR32","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02053-2022","author":"B Herrero-Cortina","year":"2023","unstructured":"Herrero-Cortina B, Lee AL, Oliveira A, O\u2019Neill B, J\u00e1come C, Dal Corso S, et al. European respiratory society statement on airway clearance techniques in adults with bronchiectasis. Eur Respir J. 2023. https:\/\/doi.org\/10.1183\/13993003.02053-2022.","journal-title":"Eur Respir J"},{"issue":"25","key":"1324_CR33","first-page":"434","volume":"120","author":"K Kahnert","year":"2023","unstructured":"Kahnert K, J\u00f6rres RA, Behr J, Welte T. The diagnosis and treatment of COPD and its comorbidities. Dtsch Arztebl Int. 2023;120(25):434.","journal-title":"Dtsch Arztebl Int"},{"issue":"10150","key":"1324_CR34","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S0140-6736(18)31554-X","volume":"392","author":"AB Chang","year":"2018","unstructured":"Chang AB, Bush A, Grimwood K. Bronchiectasis in children: diagnosis and treatment. Lancet. 2018;392(10150):866\u201379.","journal-title":"Lancet"},{"issue":"6","key":"1324_CR35","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1164\/rccm.201303-0411CI","volume":"188","author":"PJ McShane","year":"2013","unstructured":"McShane PJ, Naureckas ET, Tino G, Strek ME. Non\u2013cystic fibrosis bronchiectasis. Am J Respir Crit Care Med. 2013;188(6):647\u201356.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1324_CR36","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1164\/rccm.202306-1066ST","volume":"208","author":"CL Rochester","year":"2023","unstructured":"Rochester CL, Alison JA, Carlin B, Jenkins AR, Cox NS, Bauldoff G, et al. Pulmonary rehabilitation for adults with chronic respiratory disease: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2023;208(4):e7\u201326.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1324_CR37","doi-asserted-by":"publisher","first-page":"629","DOI":"10.5606\/tgkdc.dergisi.2020.19389","volume":"28","author":"S\u015eE G\u00fclhan","year":"2020","unstructured":"G\u00fclhan S\u015eE, Acar LN, G\u00fcven ES, B\u0131\u00e7ak\u00e7\u0131o\u011flu P, Ayd\u0131n E, Karasu S, et al. Surgical treatment of bronchiectasis: our 23 years of experience. Turkish J Thorac Cardiovasc Surgery. 2020;28(4):629.","journal-title":"Turkish J Thorac Cardiovasc Surgery"},{"issue":"10","key":"1324_CR38","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","volume":"7","author":"IF Laska","year":"2019","unstructured":"Laska IF, Crichton ML, Shoemark A, Chalmers JD. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(10):855\u201369.","journal-title":"Lancet Respir Med"},{"issue":"3","key":"1324_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10030326","volume":"10","author":"R Inchingolo","year":"2021","unstructured":"Inchingolo R, Pierandrei C, Montemurro G, Smargiassi A, Lohmeyer FM, Rizzi A. Antimicrobial resistance in common respiratory pathogens of chronic bronchiectasis patients: a literature review. Antibiotics (Basel). 2021;10(3):326.","journal-title":"Antibiotics (Basel)"},{"issue":"6","key":"1324_CR40","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1080\/02770903.2021.1904979","volume":"59","author":"S Wang","year":"2022","unstructured":"Wang S, Zhang J, Zhang C, Shao C. Clinical characteristics of allergic bronchopulmonary aspergillosis in patients with and without bronchiectasis. J Asthma. 2022;59(6):1162\u20138.","journal-title":"J Asthma"},{"issue":"2","key":"1324_CR41","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/crj.13111","volume":"14","author":"HW Lu","year":"2020","unstructured":"Lu HW, Mao B, Wei P, Jiang S, Wang H, Li CW, et al. The clinical characteristics and prognosis of ABPA are closely related to the mucus plugs in central bronchiectasis. Clin Respir J. 2020;14(2):140\u20137.","journal-title":"Clin Respir J"},{"issue":"5","key":"1324_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1080\/17476348.2021.1906225","volume":"15","author":"C Vidaillac","year":"2021","unstructured":"Vidaillac C, Chotirmall SH. Pseudomonas aeruginosa in bronchiectasis: infection, inflammation, and therapies. Expert Rev Respir Med. 2021;15(5):649\u201362.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"1324_CR43","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1080\/07853890.2021.1900594","volume":"53","author":"R Wang","year":"2021","unstructured":"Wang R, Ding S, Lei C, Yang D, Luo H. The contribution of Pseudomonas aeruginosa infection to clinical outcomes in bronchiectasis: a prospective cohort study. Ann Med. 2021;53(1):459\u201369.","journal-title":"Ann Med"},{"issue":"1","key":"1324_CR44","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ccm.2021.11.009","volume":"43","author":"CS Haworth","year":"2022","unstructured":"Haworth CS, Floto RA. Antibiotic management in bronchiectasis. Clin Chest Med. 2022;43(1):165\u201377.","journal-title":"Clin Chest Med"},{"issue":"8","key":"1324_CR45","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1513\/AnnalsATS.202108-965OC","volume":"19","author":"AK Mossman","year":"2022","unstructured":"Mossman AK, Svishchuk J, Waddell BJM, Izydorczyk CS, Buckley PT, Hilliard JJ, et al. Staphylococcus aureus in Non\u2013Cystic Fibrosis Bronchiectasis: Prevalence and Genomic Basis of High Inoculum \u03b2-Lactam Resistance. Ann Am Thorac Soc. 2022;19(8):1285\u201393.","journal-title":"Ann Am Thorac Soc"},{"issue":"18","key":"1324_CR46","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s40265-021-01635-6","volume":"81","author":"D Reynolds","year":"2021","unstructured":"Reynolds D, Kollef M. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs. 2021;81(18):2117\u201331.","journal-title":"Drugs"},{"key":"1324_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.01.045","author":"R Cordeiro","year":"2024","unstructured":"Cordeiro R, Choi H, Haworth CS, Chalmers JD. The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: updated systematic review and meta-analysis. Chest. 2024. https:\/\/doi.org\/10.1016\/j.chest.2024.01.045.","journal-title":"Chest"},{"issue":"1","key":"1324_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40265-021-01646-3","volume":"82","author":"M\u00c1 Mart\u00ednez-Garc\u00eda","year":"2022","unstructured":"Mart\u00ednez-Garc\u00eda M\u00c1, Oscullo G, Garc\u00eda-Ortega A, Matera MG, Rogliani P, Cazzola M. Rationale and clinical use of bronchodilators in adults with bronchiectasis. Drugs. 2022;82(1):1\u201313.","journal-title":"Drugs"},{"issue":"2","key":"1324_CR49","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ccm.2012.02.008","volume":"33","author":"GB Nair","year":"2012","unstructured":"Nair GB, Ilowite JS. Pharmacologic agents for mucus clearance in bronchiectasis. Clin Chest Med. 2012;33(2):363\u201370.","journal-title":"Clin Chest Med"},{"issue":"5","key":"1324_CR50","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jcf.2022.04.018","volume":"21","author":"MA Martinez-Garcia","year":"2022","unstructured":"Martinez-Garcia MA, Sierra-P\u00e1rraga JM, Quintana E, L\u00f3pez-Campos JL. CFTR dysfunction and targeted therapies: a vision from non-cystic fibrosis bronchiectasis and COPD. J Cyst Fibros. 2022;21(5):741\u20134.","journal-title":"J Cyst Fibros"},{"issue":"6","key":"1324_CR51","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1002\/ppul.25275","volume":"56","author":"C Du Berry","year":"2021","unstructured":"Du Berry C, Westrupp N, Shanthikumar S, Welsh L. Associations between peak oxygen uptake, lung function, and bronchiectasis in children with cystic fibrosis in the era of CFTR modulators. Pediatr Pulmonol. 2021;56(6):1490\u20135.","journal-title":"Pediatr Pulmonol"},{"key":"1324_CR52","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0058-2024","author":"E Van Braeckel","year":"2024","unstructured":"Van Braeckel E, Bosteels C. Growing from common ground: nontuberculous mycobacteria and bronchiectasis. Eur Respir Rev. 2024. https:\/\/doi.org\/10.1183\/16000617.0058-2024.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"1324_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98122-5","volume":"11","author":"NS Joo","year":"2021","unstructured":"Joo NS, Cho H-J, Shinbashi M, Choi JY, Milla CE, Engelhardt JF, et al. Combined agonists act synergistically to increase mucociliary clearance in a cystic fibrosis airway model. Sci Rep. 2021;11(1):18828.","journal-title":"Sci Rep"},{"issue":"9","key":"1324_CR54","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1164\/rccm.200409-1269OC","volume":"171","author":"TM McKeever","year":"2005","unstructured":"McKeever TM, Lewis SA, Smit HA, Burney P, Britton JR, Cassano PA. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. Am J Respir Crit Care Med. 2005;171(9):966\u201371.","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"1324_CR55","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s11095-023-03571-4","volume":"40","author":"U B\u0105k","year":"2023","unstructured":"B\u0105k U, Krupa A. Challenges and opportunities for celecoxib repurposing. Pharm Res. 2023;40(10):2329\u201345.","journal-title":"Pharm Res"},{"issue":"1","key":"1324_CR56","doi-asserted-by":"publisher","DOI":"10.21037\/atm-22-3437","volume":"11","author":"H Choi","year":"2022","unstructured":"Choi H, Chalmers JD. Bronchiectasis exacerbation: a narrative review of causes, risk factors, management and prevention. Ann Transl Med. 2022;11(1):25.","journal-title":"Ann Transl Med"},{"key":"1324_CR57","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S150250","author":"Y-h Gao","year":"2018","unstructured":"Gao Y-h, Guan W-j, Zhu Y-n, Chen R-c, Zhang G-j. Antibiotic-resistant Pseudomonas aeruginosa infection in patients with bronchiectasis: prevalence, risk factors and prognostic implications. Int J Chron Obstruct Pulmon Dis. 2018. https:\/\/doi.org\/10.2147\/COPD.S150250.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"7","key":"1324_CR58","doi-asserted-by":"publisher","first-page":"3636","DOI":"10.21037\/jtd-22-1541","volume":"15","author":"H Seo","year":"2023","unstructured":"Seo H, Cha S-I, Park J, Lim J-K, Park J-E, Choi SH, et al. Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea. J Thorac Dis. 2023;15(7):3636.","journal-title":"J Thorac Dis"},{"issue":"1","key":"1324_CR59","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/rheumatology\/keaa327","volume":"60","author":"EH Ibfelt","year":"2021","unstructured":"Ibfelt EH, Jacobsen RK, Kopp TI, Cordtz RL, Jakobsen AS, Seersholm N, et al. Methotrexate and risk of interstitial lung disease and respiratory failure in rheumatoid arthritis: a nationwide population-based study. Rheumatology. 2021;60(1):346\u201352.","journal-title":"Rheumatology"},{"issue":"1","key":"1324_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-023-02391-9","volume":"24","author":"L-L Wang","year":"2023","unstructured":"Wang L-L, Lu H-W, Li L-L, Gao Y-H, Xu Y-H, Li H-X, et al. Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study. Respir Res. 2023;24(1):84.","journal-title":"Respir Res"},{"key":"1324_CR61","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04388-2020","author":"P Bedi","year":"2021","unstructured":"Bedi P, Cartlidge MK, Zhang Y, Turnbull K, Donaldson S, Clarke A, et al. Feasibility of shortening intravenous antibiotic therapy for bronchiectasis based on bacterial load: a proof-of-concept randomised controlled trial. Eur Respir J. 2021. https:\/\/doi.org\/10.1183\/13993003.04388-2020.","journal-title":"Eur Respir J"},{"issue":"2","key":"1324_CR62","first-page":"139","volume":"32","author":"Y Yuan-hang","year":"2023","unstructured":"Yuan-hang Y, Cheng L, Jia K, Jing K, Yuan-ying S. Research progress of TCM syndromes and TCM treatment of bronchiectasis. Chin J Convalesc Med. 2023;32(2):139\u201343.","journal-title":"Chin J Convalesc Med"},{"key":"1324_CR63","unstructured":"Shasha Y, Changzheng F, Maorong F, Qing M. Guidelines for Integrated Chinese and Western Medicine Treatment of Bronchiectasis. Chinese J of Exp Trad Med Form."},{"issue":"8","key":"1324_CR64","first-page":"831","volume":"42","author":"L Guang-sen","year":"2023","unstructured":"Guang-sen L, Bing W, Mao-rong F, Wen-wen S, Wen-wen W, Qing-xiang M, et al. Exploration of whole course diagnosis and treatment of bronchiectasis based on the theory of \u201cPhlegm-Toxicity.\u201d Beijing J Tradit Chinese Med. 2023;42(8):831\u20134.","journal-title":"Beijing J Tradit Chinese Med"},{"issue":"3","key":"1324_CR65","first-page":"291","volume":"42","author":"C Hong-li","year":"2023","unstructured":"Hong-li C, Hong-chun Z. Analysis on the characteristics of ZHANG Hong-chun\u2019s combined treatment of bronchiectasis based on syndrome differentiation by stages and five states. Beijing J Tradit Chin Med. 2023;42(3):291\u20133.","journal-title":"Beijing J Tradit Chin Med"},{"issue":"35","key":"1324_CR66","first-page":"5003","volume":"27","author":"Z Shenghan","year":"2016","unstructured":"Shenghan Z, Zhigang D, Suhua Z. Clinical observation of Qingjin Huatan Decoction for patients with AECOPD phlegm-heat obstructing lung. China Pharm. 2016;27(35):5003\u20135.","journal-title":"China Pharm"},{"issue":"12","key":"1324_CR67","first-page":"70","volume":"51","author":"H Dingkao","year":"2019","unstructured":"Dingkao H, Limin C. Study on the effect of Qianjin Weijing Tang on PCT and SOFA scores in patients with severe pneumonia of phlegm-heat obstructing lungs type. J New Chin Med. 2019;51(12):70\u20132.","journal-title":"J New Chin Med"},{"issue":"4","key":"1324_CR68","first-page":"788","volume":"19","author":"W Qi-biao","year":"2008","unstructured":"Qi-biao W, Shi-hong C, Jin-fu L, Qing-guo D, Zi-kai S. Effect of Zhikuoning mixture on expression of TNF-\u03b1 in human bronchial epithelial cells in vitro study. Lishizhen Med Mater Med Res. 2008;19(4):788\u20139.","journal-title":"Lishizhen Med Mater Med Res"},{"issue":"24","key":"1324_CR69","first-page":"118","volume":"27","author":"Y Sha-sha","year":"2021","unstructured":"Sha-sha Y, Ning W, Qing M. Clinical observation of Bupi Qingfei decoction in treatment of bronchiectasis colonized by Pseudomonas aeruginosa. Chinese J of Exp Trad Med Form. 2021;27(24):118\u201324.","journal-title":"Chinese J of Exp Trad Med Form"},{"issue":"08","key":"1324_CR70","first-page":"819","volume":"42","author":"QLY Xiao-yu","year":"2023","unstructured":"Xiao-yu QLY, Jia-jun C, Shao-yan Z, Ding-zhong W, Hui-yong Z, Pei-yong Z, et al. Observation on curative effect of Sangbaipi Decoction combined with routine western medicine in treating bronchiectasis with phlegm-heat obstructing lung syndrome. Beijing J Tradit Chinese Med. 2023;42(08):819\u201323.","journal-title":"Beijing J Tradit Chinese Med"},{"issue":"4","key":"1324_CR71","first-page":"416","volume":"43","author":"Z Yunqing","year":"2022","unstructured":"Yunqing Z, Xiufeng W, Xiaoxia D, Shudong Y, Li W. Effect of Kuandonghua formula on airway inflammation in rats for bronchiectasis with the phlegm-heat stagnation syndrome. Shaanxi J Tradit Chin Med. 2022;43(4):416\u201320.","journal-title":"Shaanxi J Tradit Chin Med"},{"key":"1324_CR72","unstructured":"Huan-chun Z, Juan-juan G, Hai-qiong L, Jia S, Hong-xia W. Effect of Qingjin Beilou Decoction Combined with Non-Invasive Positive Pressure Ventilation in Treating Bronchiectasis(Phlegm-Heat Obstructing the Lung) and Its Effect on Serum Levels of HNP1\u20133,MCP-1 and MMP-9. World Journal of Integrated Traditional and Western Medicine. 2021. 2."},{"issue":"10","key":"1324_CR73","first-page":"33","volume":"25","author":"L Xinping","year":"2021","unstructured":"Xinping L, Zhanru W, Qing Y. Efficacy of supplemented Cangma pills in treatment of patients with acute exacerbation of bronchiectasis differentiated as syndrome of stagnation of phlegm-dampness in lung. J Clin Med Pract. 2021;25(10):33\u20136.","journal-title":"J Clin Med Pract"},{"issue":"8","key":"1324_CR74","first-page":"1236","volume":"40","author":"Y Wan-lin","year":"2024","unstructured":"Wan-lin Y, Ying-shan Z. Research status of Erchen decoction in the treatment of respiratory diseases. Chin J Clin Pharmacol. 2024;40(8):1236\u201340.","journal-title":"Chin J Clin Pharmacol"},{"issue":"07","key":"1324_CR75","first-page":"94","volume":"15","author":"G Dekun","year":"2017","unstructured":"Dekun G, Yong M, Bin L. Gleditsiae pill in the adjuvant treatment of turbid phlegm obstructing lung bronchiectasis in\nacute exacerbation for 32 cases. Chin Med Mod Distance Educ China. 2017;15(07):94\u20135.","journal-title":"Chin Med Mod Distance Educ China"},{"issue":"5","key":"1324_CR76","first-page":"226","volume":"3","author":"Z Jing-rong","year":"2017","unstructured":"Jing-rong Z, Yi-xin X, Cheng L. With Xiebai Powder Qingzhaojiufei Decoction Jiawei clinical observation on the treatment of bronchiectasis. Smart Healthcare. 2017;3(5):226\u20137+55.","journal-title":"Smart Healthcare"},{"issue":"1","key":"1324_CR77","first-page":"1","volume":"24","author":"X Jie","year":"2006","unstructured":"Jie X, Lili W. Observation on the therapeutic effect of modified Daige san in treating bronchiectasis with hemoptysis. Chin Arch Tradit Chin Med. 2006;24(1):1.","journal-title":"Chin Arch Tradit Chin Med"},{"issue":"1","key":"1324_CR78","first-page":"4931284","volume":"2022","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang X, Fu H, Kou S, Huang D, Shen Z, et al. Yunnan Baiyao adjuvant treatment for patients with hemoptysis: a systematic review and meta-analysis. Evidence-Based Complem Alternat Med. 2022;2022(1):4931284.","journal-title":"Evidence-Based Complem Alternat Med"},{"key":"1324_CR79","unstructured":"Guang X, Wei X, Sheng C, Jinglai Q, Xue G. Clinical observation on treating bronchiectasis hemoptysis with Gao\u2019s Sishun Qingliang Yin. Clinical Journal of Chinese Medicine. 2020."},{"issue":"17","key":"1324_CR80","first-page":"47","volume":"17","author":"T Shaojun","year":"2024","unstructured":"Shaojun T. Clinical effect of Luohuazizhu granules in the adjuvant treatment of pulmonary hemoptysis and its influence on coagulation function and inflammatory factor levels. Chin J Clin Ration Drug Use. 2024;17(17):47\u201350.","journal-title":"Chin J Clin Ration Drug Use"},{"issue":"22","key":"1324_CR81","first-page":"5344","volume":"45","author":"F Yi-Ling","year":"2020","unstructured":"Yi-Ling F, Qing M, Xing L, Chang-Zheng F, Mao-Rong F, Qing C, et al. Systematic review and Meta-analysis on efficacy and safety of Buzhong Yiqi Decoction for stable chronic obstructive pulmonary disease. Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China Journal of Chinese materia medica. 2020;45(22):5344\u201355.","journal-title":"Zhongguo Zhong yao za zhi= Zhongguo zhongyao zazhi= China Journal of Chinese materia medica"},{"issue":"22","key":"1324_CR82","first-page":"99","volume":"8","author":"WR H","year":"2024","unstructured":"H WR, T X, X HX, O L. Effects of sangbaipi decoction on serum inflammation levels and T lymphocyte subsets in patients with bronchiectasis. Mod Med Health Res Electron J. 2024;8(22):99\u2013102.","journal-title":"Mod Med Health Res Electron J"},{"issue":"08","key":"1324_CR83","first-page":"54","volume":"54","author":"Y L","year":"2022","unstructured":"L Y, W W, S Y. Clinical study on modified Wanfei Yin for bronchiectasis with syndrome of deficiency of Qi and Yin. New Chin Med. 2022;54(08):54\u20136.","journal-title":"New Chin Med"},{"key":"1324_CR84","unstructured":"Siyi TU, Yanling G, Guizhen Y. Clinical observation on modified liujunzi decoction in the treatment of stably chronic obstructive pulmonary disease with lung spleen Qi deficiency syndrome. Chinese Medicine Modern Distance Education of China. 2018."},{"issue":"22","key":"1324_CR85","first-page":"3308","volume":"32","author":"Z Mingzhe","year":"2017","unstructured":"Mingzhe Z, Xiaoya L. Clinical study on Baihe Gujin decoction combined with western medicine in the treatment of outpatient bronchiectasis complicated with infection of hyperactivity of lung Qi due to Yin deficiency. Guangming J Chin Med. 2017;32(22):3308\u201310.","journal-title":"Guangming J Chin Med"},{"key":"1324_CR86","unstructured":"Jian-sheng L, Zhi-wan W, Jia-jia W, Hong-sheng C, Miao Z, Zhan-ping M, et al. Chinese Medicine treatment for bronchiectasis: a multicenter randomized controlled trial. Chinese Journal of Integrated Traditional and Western Medicine. 44 (2):156\u201362."},{"key":"1324_CR87","unstructured":"Jinwen G. Clinical Observation on Qingjin Huatan Decoction in the treatment of bronchiectasis with phlegm-heat congestion type. Chinese Medicine Modern Distance Education of China. 2022."},{"key":"1324_CR88","unstructured":"Chengxin L, Zeting Z, Huiqiu L, Xiaofang L, Xiufang H, Xiaohong L, et al. A Series of N-of-1 Trials on the Treatment of Stable Stage of Bronchiectasis (Phlegm Heat Accumulating in the Lung Pattern) with Modified Weijing decoction. Traditional Chinese Drug Research & Clinical Pharmacology. 2024. 35(6)."},{"issue":"1","key":"1324_CR89","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12943-025-02245-6","volume":"24","author":"Z Xi","year":"2025","unstructured":"Xi Z, Dai R, Ze Y, Jiang X, Liu M, Xu H. Traditional Chinese medicine in lung cancer treatment. Mol Cancer. 2025;24(1):57.","journal-title":"Mol Cancer"},{"issue":"5","key":"1324_CR90","first-page":"52","volume":"22","author":"W Qi-biao","year":"2008","unstructured":"Qi-biao W, Huan-yi L, Jin-fu L. Effect of\"Zhikuoning Mixture\"on expression of MMP-9 mRNA in the lungs of bronchiectatic rats. Acta Univ Tradit Med Sin Pharmacol Shanghai. 2008;22(5):52\u20134.","journal-title":"Acta Univ Tradit Med Sin Pharmacol Shanghai"},{"issue":"1","key":"1324_CR91","first-page":"211","volume":"36","author":"Z Yaofu","year":"2021","unstructured":"Yaofu Z. Zhao Jinxi\u2019s experience in treating post-infectious cough with the\" trinity\" diagnosis and treatment model of identification of body constitution, disease and evidence [J]. Chin J Tradit Chin Med. 2021;36(1):211\u20133.","journal-title":"Chin J Tradit Chin Med"},{"key":"1324_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.eujim.2024.102418","author":"L Zhang","year":"2024","unstructured":"Zhang L, Su J, Wu X, Li W, Chen Y. Effectiveness and safety of Qianjinweijing decoction in the treatment of bronchiectasis: a systematic review and meta-analysis. Eur J Integr Med. 2024. https:\/\/doi.org\/10.1016\/j.eujim.2024.102418.","journal-title":"Eur J Integr Med"},{"key":"1324_CR93","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s12016-012-8332-0","volume":"44","author":"H-D Ma","year":"2013","unstructured":"Ma H-D, Deng Y-R, Tian Z, Lian Z-X. Traditional Chinese medicine and immune regulation. Clin Rev Allergy Immunol. 2013;44:229\u201341.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"1324_CR94","first-page":"74","volume":"26","author":"H Congrui","year":"2020","unstructured":"Congrui H, Fuyuan F, Wanghua L. Study on the distribution patterns of TCM syndrome types and syndrome elements of bronchiectasis based on modern literature. Guid J Tradit Chin Med Pharm. 2020;26(7):74\u20137.","journal-title":"Guid J Tradit Chin Med Pharm"},{"issue":"1","key":"1324_CR95","first-page":"98","volume":"26","author":"D Guan-lin","year":"2020","unstructured":"Guan-lin D, Zhen-gang Z, Yan-long Z. Clinical efficacy of modified Qingjin Huatan Tang on bronchiectasis with syndrome of phlegm-heat accumulating lung at acute exacerbation. Chin J Exp Trad Med Form. 2020;26(1):98\u2013103.","journal-title":"Chin J Exp Trad Med Form"},{"issue":"1","key":"1324_CR96","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1089\/acm.1995.1.57","volume":"1","author":"KA Jobst","year":"1995","unstructured":"Jobst KA. A critical analysis of acupuncture in pulmonary disease: efficacy and safety of the acupuncture needle. J Altern Complement Med. 1995;1(1):57\u201385.","journal-title":"J Altern Complement Med"},{"issue":"4","key":"1324_CR97","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1365-2702.2005.01515.x","volume":"16","author":"SH Maa","year":"2007","unstructured":"Maa SH, Tsou TS, Wang KY, Wang CH, Lin HC, Huang YH. Self\u2010administered acupressure reduces the symptoms that limit daily activities in bronchiectasis patients: pilot study findings. J Clin Nurs. 2007;16(4):794\u2013804.","journal-title":"J Clin Nurs"},{"key":"1324_CR98","unstructured":"Ai J, Qi H, Feng W-J, Ji X-H. Clinical study on the treatment of bronchiectasis in remission period by embedding thread combined with Jianpi Qushi Huayu plaster. Journal of Hainan Medical University. 2020. 26(16)."},{"issue":"04","key":"1324_CR99","first-page":"457","volume":"17","author":"Z Chunjiao","year":"2022","unstructured":"Chunjiao Z, Jie F, Ting Z. Effect of respiratory rehabilitation combined with acupuncture and moxibustion on patients with bronchiectasis complicated by pseudomonas aeruginosa infection. Intern Med. 2022;17(04):457\u201361.","journal-title":"Intern Med"},{"issue":"1","key":"1324_CR100","first-page":"72","volume":"16","author":"K Schoovaerts","year":"2019","unstructured":"Schoovaerts K, Lorent N, Goeminne P, Aliberti S, Dupont L. National survey on the management of adult bronchiectasis in Belgium. COPD J Chronic Obstr Pulm Dis. 2019;16(1):72\u20134.","journal-title":"COPD J Chronic Obstr Pulm Dis"},{"issue":"2","key":"1324_CR101","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/art.41512","volume":"73","author":"L Chauvelot","year":"2021","unstructured":"Chauvelot L, Gamondes D, Berthiller J, Nieves A, Renard S, Catella-Chatron J, et al. Hemodynamic response to treatment and outcomes in pulmonary hypertension associated with interstitial lung disease versus pulmonary arterial hypertension in systemic sclerosis: data from a study identifying prognostic factors in pulmonary hypertension associated with interstitial lung disease. Arthritis Rheumatol. 2021;73(2):295\u2013304.","journal-title":"Arthritis Rheumatol"},{"issue":"7629","key":"1324_CR102","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1136\/bmj.39384.657118.80","volume":"335","author":"NH ten Hacken","year":"2007","unstructured":"ten Hacken NH, Wijkstra PJ, Kerstjens HA. Treatment of bronchiectasis in adults. BMJ. 2007;335(7629):1089\u201393.","journal-title":"BMJ"},{"key":"1324_CR103","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00017-2022","author":"J-f Xu","year":"2022","unstructured":"Xu J-f, Gao Y-h, Song Y-l, Qu J-m, Guan W-j. Research advances and clinical management of bronchiectasis: Chinese perspective. ERJ Open Res. 2022. https:\/\/doi.org\/10.1183\/23120541.00017-2022.","journal-title":"ERJ Open Res"},{"issue":"24","key":"1324_CR104","first-page":"70","volume":"41","author":"C Jing-jing","year":"2023","unstructured":"Jing-jing C, Nian-zhi Z, Xiao-ming X, Ming-xiang H. Research progress of Traditional Chinese Medicine in the treatment of bronchiectasis and related mechanisms. Zhonghua Yangsheng Baojian. 2023;41(24):70.","journal-title":"Zhonghua Yangsheng Baojian"},{"key":"1324_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2021.102061","volume":"70","author":"H Zhang","year":"2021","unstructured":"Zhang H, Liu B, Jiang S, Wu J-F, Qi C-H, Mohammadtursun N, et al. Baicalin ameliorates cigarette smoke-induced airway inflammation in rats by modulating HDAC2\/NF-\u03baB\/PAI-1 signalling. Pulm Pharmacol Ther. 2021;70:102061.","journal-title":"Pulm Pharmacol Ther"},{"issue":"4","key":"1324_CR106","volume":"16","author":"S Tao","year":"2021","unstructured":"Tao S, Yun S, Yinxue M, Xin Y, Kunming Q. Chemical composition and antibacterial activity of the essential oil isolated from Flos Lonicerae (Flower Buds of Lonicera macranthoides Hand.-Mazz.). Nat Prod Commun. 2021;16(4):1934578X211008318.","journal-title":"Nat Prod Commun"},{"issue":"1","key":"1324_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-015-0044-y","volume":"10","author":"Y-p Guo","year":"2015","unstructured":"Guo Y-p, Lin L-g, Wang Y-t. Chemistry and pharmacology of the herb pair Flos Lonicerae japonicae-Forsythiae fructus. Chin Med. 2015;10(1):16.","journal-title":"Chin Med"},{"issue":"01","key":"1324_CR108","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1142\/S0192415X17500100","volume":"45","author":"J-J Chen","year":"2017","unstructured":"Chen J-J, Huang C-C, Chang H-Y, Li P-Y, Liang Y-C, Deng J-S, et al. Scutellaria baicalensis ameliorates acute lung injury by suppressing inflammation in vitro and in vivo. Am J Chin Med. 2017;45(01):137\u201357.","journal-title":"Am J Chin Med"},{"issue":"4","key":"1324_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176883","volume":"12","author":"J Luo","year":"2017","unstructured":"Luo J, Dong B, Wang K, Cai S, Liu T, Cheng X, et al. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model. PLoS ONE. 2017;12(4):e0176883.","journal-title":"PLoS ONE"},{"key":"1324_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113018","volume":"141","author":"J-W Kim","year":"2024","unstructured":"Kim J-W, Jeong J-S, Kim J-H, Kim C-Y, Chung E-H, Ko J-W, et al. Turmeric extract alleviates airway inflammation via oxidative stress-driven MAPKs\/MMPs pathway. Int Immunopharmacol. 2024;141:113018.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1324_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/s13020-024-00954-6","volume":"19","author":"Y-Z Wu","year":"2024","unstructured":"Wu Y-Z, Zhang Q, Li H, Jiang C-X, Li X-K, Shang H-C, et al. Zedoary turmeric oil injection ameliorates lung inflammation via platelet factor 4 and regulates gut microbiota disorder in respiratory syncytial virus-infected young mice. Chin Med. 2024;19(1):83.","journal-title":"Chin Med"},{"issue":"6","key":"1324_CR112","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12272-022-01393-3","volume":"45","author":"C-X Li","year":"2022","unstructured":"Li C-X, Liu Y, Zhang Y-Z, Li J-C, Lai J. Astragalus polysaccharide: a review of its immunomodulatory effect. Arch Pharm Res. 2022;45(6):367\u201389.","journal-title":"Arch Pharm Res"},{"key":"1324_CR113","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.952061","volume":"13","author":"C Liu","year":"2022","unstructured":"Liu C, Wang S, Xiang Z, Xu T, He M, Xue Q, et al. The chemistry and efficacy benefits of polysaccharides from Atractylodes macrocephala Koidz. Front Pharmacol. 2022;13:952061.","journal-title":"Front Pharmacol"},{"issue":"4","key":"1324_CR114","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1007\/s11101-024-09995-z","volume":"24","author":"Q Wang","year":"2025","unstructured":"Wang Q, Li Y, Gao P, Dai L. Modern research progress on extraction and purification, pharmacological activity, toxicology, pharmacokinetics and carrier new dosage forms of ophiopogonin. Phytochem Rev. 2025;24(4):2553\u201386.","journal-title":"Phytochem Rev"},{"key":"1324_CR115","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.1033875","volume":"13","author":"K Ming","year":"2022","unstructured":"Ming K, Zhuang S, Ma N, Nan S, Li Q, Ding M, et al. Astragalus polysaccharides alleviates lipopolysaccharides-induced inflammatory lung injury by altering intestinal microbiota in mice. Front Microbiol. 2022;13:1033875.","journal-title":"Front Microbiol"},{"issue":"1","key":"1324_CR116","volume":"2023","author":"BK Shah","year":"2023","unstructured":"Shah BK, Singh B, Wang Y, Xie S, Wang C. Mucus hypersecretion in chronic obstructive pulmonary disease and its treatment. Mediators Inflamm. 2023;2023(1):8840594.","journal-title":"Mediators Inflamm"},{"issue":"05","key":"1324_CR117","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1142\/S0192415X16500579","volume":"44","author":"W Du","year":"2016","unstructured":"Du W, Su J, Ye D, Wang Y, Huang Q, Gong X. Pinellia ternata attenuates mucus secretion and airway inflammation after inhaled corticosteroid withdrawal in COPD rats. Am J Chin Med. 2016;44(05):1027\u201341.","journal-title":"Am J Chin Med"},{"issue":"1","key":"1324_CR118","first-page":"E8761429360075","volume":"17","author":"L Zou","year":"2024","unstructured":"Zou L, Yu X, Tang L, Guo C, Sun Z, Li S, et al. Targeting airway remodeling in asthma: Anti-EMT Effects of Xuanfei Pingchuan prescription via TGF\u03b21\/Smad pathway modulation. Curr Mol Pharmacol. 2024;17(1):E8761429360075.","journal-title":"Curr Mol Pharmacol"},{"issue":"9","key":"1324_CR119","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1080\/14656566.2023.2210763","volume":"24","author":"X-X Zhang","year":"2023","unstructured":"Zhang X-X, Chen Z-M, He Z-F, Guan W-J. Advances in pharmacotherapy for bronchiectasis in adults. Expert Opin Pharmacother. 2023;24(9):1075\u201389.","journal-title":"Expert Opin Pharmacother"},{"issue":"16","key":"1324_CR120","first-page":"49","volume":"8","author":"T Zhaohua","year":"2018","unstructured":"Zhaohua T. Clinical effects of Jiawei Qingjin Huatan decoction on bronchiectasis patients with phlegm-heat obstructing lung syndrome. China Med Pharm. 2018;8(16):49\u201352.","journal-title":"China Med Pharm"},{"issue":"11","key":"1324_CR121","first-page":"1190","volume":"26","author":"D Fei","year":"2017","unstructured":"Fei D. The efficacy of modified Qingjin Huatan decoction combined with bronchoscopic alveolar lavage in the treatment of bronchiectasis complicated with infection and its effect on serum inflammatory factors. Mod J Integr Tradit Chinese West Med. 2017;26(11):1190\u20132+200.","journal-title":"Mod J Integr Tradit Chinese West Med"},{"issue":"01","key":"1324_CR122","first-page":"147","volume":"35","author":"W Liying","year":"2023","unstructured":"Liying W, Yinzhe G, Runshao T. Observation on clinical curative effect of modified Qingjin Huatan decoction in treating patients with bronchiectasis complicated with pulmonary infection. Clin J Tradit Chinese Med. 2023;35(01):147\u201351.","journal-title":"Clin J Tradit Chinese Med"},{"issue":"18","key":"1324_CR123","first-page":"80","volume":"23","author":"Y Xing-zhi","year":"2017","unstructured":"Xing-zhi Y, Ning R, Wei-feng T. Effect of Qingfei Huatan decoction on the levels of WBC,NEU and LYM in peripheral blood of patients with acute bronchial asthma of phlegm heat obstructing the lung. Guiding J Tradit Chinese Med Pharm. 2017;23(18):80\u20132.","journal-title":"Guiding J Tradit Chinese Med Pharm"},{"issue":"02","key":"1324_CR124","first-page":"91","volume":"11","author":"J Fei-fei","year":"2019","unstructured":"Fei-fei J. Clinical observation of patients with bronchiectasis due to phlegm-heat obstructing the lungs treated with Qingfei Huatan decoction. Res Integr Tradit Chinese West Med. 2019;11(02):91\u20132+5.","journal-title":"Res Integr Tradit Chinese West Med"},{"issue":"03","key":"1324_CR125","first-page":"666","volume":"35","author":"Y Hong-mei","year":"2024","unstructured":"Hong-mei Y, Jie-zhen Y, Qing-hong Z, Ling P, Mei-qun L, Wei L, et al. Effect of Qingfei Huatan decoction on airway mucus hypersecretion in patients with acute exacerbation of bronchiectasis with phlegm-heat obstructive pulmonary syndrome. Lishizhen Med Materia Medica Res. 2024;35(03):666\u20138.","journal-title":"Lishizhen Med Materia Medica Res"},{"issue":"02","key":"1324_CR126","first-page":"271","volume":"31","author":"L Yanling","year":"2022","unstructured":"Yanling L, Fang C, Wenhui X. Clinical efficacy of Weijing Erchen decoction in treating patients with acute exacerbations of bronchiectasis (phlegm-heat stagnation in the lungs syndrome). J Emerg Tradit Chin Med. 2022;31(02):271\u20134.","journal-title":"J Emerg Tradit Chin Med"},{"issue":"15","key":"1324_CR127","first-page":"194","volume":"22","author":"F Bo","year":"2016","unstructured":"Bo F, Gang Z. Clinical analysis of Weijin Xiaoyong decoction in adjuvant therapy of bronchiectasis at acute exacerbation stage with syndrome of phlegm-heat obstructing lung. Chin J Exp Tradit Med Formulae. 2016;22(15):194\u20138.","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"03","key":"1324_CR128","first-page":"103","volume":"46","author":"W Youyou","year":"2018","unstructured":"Youyou W, Sheng C, Jinglai Q, Yaqiong W. Clinical study of Yulou Weijing decoction treating bronchiectasis with infection of phlegm-heat congested the lung. Acta Chin Med Pharmacol. 2018;46(03):103\u20135.","journal-title":"Acta Chin Med Pharmacol"},{"issue":"04","key":"1324_CR129","first-page":"576","volume":"47","author":"H Yuan","year":"2025","unstructured":"Yuan H, Wenxi H, Jinlin J. Effect of Xiefei Huatan prescription combined with mucolytic agent on the recovery and inflammatory factors in acute exacerbation of bronchiectasis phlegm-heat obstructing lung syndrome. Hebei J Tradit Chin Med. 2025;47(04):576\u201380.","journal-title":"Hebei J Tradit Chin Med"},{"issue":"08","key":"1324_CR130","first-page":"2523","volume":"44","author":"X Xiao-jing","year":"2022","unstructured":"Xiao-jing X, Pu Q, Ting-ting Z, Ying-ying SKG. Clinical effects of Xiefei Huatan decoction combined with conventional treatment on patients with acute exacerbation of bronchodilation. Chin Tradit Patent Med. 2022;44(08):2523\u20137.","journal-title":"Chin Tradit Patent Med"},{"issue":"04","key":"1324_CR131","first-page":"385","volume":"44","author":"Q Yu-jie","year":"2022","unstructured":"Yu-jie Q, Sheng-li J, Bo L, Yong-hua J. Therapeutic effects of modified Jiawei Jiegeng decoction on patients with stable bronchiectasis and its impacts on inflammatory cells and factors in bronchoalveolar lavage fluid. Guangxi Med J. 2022;44(04):385\u20138+93.","journal-title":"Guangxi Med J"},{"issue":"02","key":"1324_CR132","first-page":"44","volume":"14","author":"H Wenhai","year":"2022","unstructured":"Wenhai H. The effect of the Juqin decoction on clinical symptoms and pulmonary ventilation function in patients with bronchiectasis. Clin J Chin Med. 2022;14(02):44\u20137.","journal-title":"Clin J Chin Med"},{"issue":"08","key":"1324_CR133","first-page":"819","volume":"42","author":"Q Lei","year":"2023","unstructured":"Lei Q, Xiao-yu Y, Jia-jun C, Shao-yan Z, Ding-zhong W, Hui-yong Z, et al. Observation on curative effect of Sangbaipi decoction combined with routine western medicine in treating bronchiectasis with phlegm-heat obstructing lung syndrome. Beijing J Tradit Chinese Med. 2023;42(08):819\u201323.","journal-title":"Beijing J Tradit Chinese Med"},{"issue":"20","key":"1324_CR134","first-page":"169","volume":"24","author":"Z Yun-qing","year":"2018","unstructured":"Yun-qing Z, Guang-lan X, Xiu-feng W, Ping C, Tun O. Effect of Kuandonghua San for acute exacerbation of bronchiectasis with phlegm-heat stagnation syndrome. Chin J Exp Tradit Med Formulae. 2018;24(20):169\u201374.","journal-title":"Chin J Exp Tradit Med Formulae"},{"issue":"07","key":"1324_CR135","first-page":"1238","volume":"32","author":"W Mang","year":"2023","unstructured":"Mang W, Wuzhong X, Yue W, Cuiyao X, Yue P. Clinical observation of the treatment of acute exacerbations of bronchiectasis in the elderly with modified Kuandonghua san combined with Western medicine. J Emerg Tradit Chin Med. 2023;32(07):1238\u201340.","journal-title":"J Emerg Tradit Chin Med"},{"issue":"12","key":"1324_CR136","first-page":"79","volume":"52","author":"W Faliang","year":"2024","unstructured":"Faliang W, Zhen L, Dewang Y, Taiping T. Efficacy evaluation of Xuanfei Huatan Sanyu decoction in treating bronchiectasis with infection (phlegm-heat obstructing the lung syndrome). Acta Chin Med Pharmacol. 2024;52(12):79\u201383.","journal-title":"Acta Chin Med Pharmacol"},{"issue":"13","key":"1324_CR137","first-page":"2448","volume":"26","author":"T Cuiying","year":"2010","unstructured":"Cuiying T, Xiaoping T, Hui Y. Treatment of 30 cases of bronchiectasis with modified Huanglian Wendan decoction. J Pract Med. 2010;26(13):2448\u20139.","journal-title":"J Pract Med"},{"issue":"39","key":"1324_CR138","first-page":"10","volume":"18","author":"W Jun","year":"2018","unstructured":"Jun W, Xian-hao S. Clinical effect of modified Huanglian Wendan decoction on bronchiectasis. World Latest Med Inf. 2018;18(39):10\u20131.","journal-title":"World Latest Med Inf"},{"issue":"55","key":"1324_CR139","first-page":"163","volume":"16","author":"F Xv","year":"2016","unstructured":"Xv F. A study on the clinical efficacy of modified Huanglian Wendan decoction in the treatment of patients with bronchiectasis. World Latest Med Inf. 2016;16(55):163.","journal-title":"World Latest Med Inf"},{"issue":"03","key":"1324_CR140","first-page":"449","volume":"29","author":"Z Caixia","year":"2020","unstructured":"Caixia Z, Yang L, Yan W, Nianzhi Z. Clinical observation on the treatment of bronchiectasis with Qingjin Beilou decoction. J Emerg Tradit Chin Med. 2020;29(03):449\u201352.","journal-title":"J Emerg Tradit Chin Med"},{"issue":"06","key":"1324_CR141","first-page":"949","volume":"44","author":"F Mengqing","year":"2022","unstructured":"Mengqing F, Li Z, Lijie L. Clinical efficacy of Qingjin Beilou decoction for bronchiectasis of phlegm-heat obstructing lung type and how it impacts on pulmonary function and serum inflammatory factor level. Hebei J Tradit Chin Med. 2022;44(06):949\u201352.","journal-title":"Hebei J Tradit Chin Med"},{"issue":"08","key":"1324_CR142","first-page":"96","volume":"35","author":"C Jia","year":"2023","unstructured":"Jia C, Qifu C, Yuanyuan K. Effects of Qingjin Beilou decoction combined with conventional Western medicine in treatment of elderly patients with bronchiectasis. Med J Chinese People\u2019s Health. 2023;35(08):96\u20138+102.","journal-title":"Med J Chinese People\u2019s Health"},{"issue":"03","key":"1324_CR143","first-page":"507","volume":"30","author":"J Shengli","year":"2021","unstructured":"Shengli J, Shengnan Q, Yan G, Zhiying W. Effects of Huangqin Xiebai powder as an adjunct therapy on pulmonary function and inflammatory markers in patients with acute exacerbations of bronchiectasis. J Emerg Tradit Chin Med. 2021;30(03):507\u20139.","journal-title":"J Emerg Tradit Chin Med"},{"issue":"05","key":"1324_CR144","first-page":"127","volume":"49","author":"L Xia","year":"2022","unstructured":"Xia L, Jiejing L, Hong Q. Clinical effect of Jianpi Yifei decoction on bronchiectasis (stable stage) and its influence on serum inflammatory. Liaoning J Tradit Chin Med. 2022;49(05):127\u201330.","journal-title":"Liaoning J Tradit Chin Med"},{"issue":"05","key":"1324_CR145","first-page":"968","volume":"14","author":"Y Liting","year":"2021","unstructured":"Liting Y, Tingting L, Zhenbing G, Zhixing G. Treatment of 56 cases of bronchiectasis due to lung and spleen qi deficiency with Shenzhu Yangfei decoction combined with cough and asthma patch. Glob Tradit Chin Med. 2021;14(05):968\u201371.","journal-title":"Glob Tradit Chin Med"},{"issue":"06","key":"1324_CR146","first-page":"742","volume":"47","author":"M Jiajun","year":"2019","unstructured":"Jiajun M, Ming C, Yuguang W. Effects of low-dose Cangma pills on airway mucus hypersecretion during the stable phase of bronchiectasis. Chin J Clinicians. 2019;47(06):742\u20135.","journal-title":"Chin J Clinicians"},{"issue":"02","key":"1324_CR147","first-page":"151","volume":"28","author":"X Jingyi","year":"2022","unstructured":"Jingyi X. Effect of Bufei Ejiao decoction + Phentolamine in the treatment of bronchiectasis and hemoptysis and its\ninfluence on patients\u2019 quality of life. Contemp Med. 2022;28(02):151\u20133.","journal-title":"Contemp Med"},{"issue":"13","key":"1324_CR148","first-page":"46","volume":"29","author":"H Yongdu","year":"2019","unstructured":"Yongdu H. The efficacy of Baihe Gujin decoction in treating bronchiectasis complicated with infection. Shenzhen J Integr Tradit Chinese West Med. 2019;29(13):46\u20137.","journal-title":"Shenzhen J Integr Tradit Chinese West Med"},{"key":"1324_CR149","first-page":"105","volume":"18","author":"Y Xuwei","year":"2021","unstructured":"Xuwei Y, Zhenggen C. Clinical observation on the treatment of bronchiectasis with integrated traditional Chinese and Western Medicine. Diet Health Care. 2021;18:105.","journal-title":"Diet Health Care"},{"key":"1324_CR150","unstructured":"Societies RDPCotWFoCM. Expert Consensus on the Diagnosis and Treatment of Bronchiectasis with Integrated Traditional Chinese and Western Medicine. Journal of Traditional Chinese Medicine. 2022. 63 22 2196\u2013200."},{"key":"1324_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106083","volume":"176","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang X, Li Y, Xue Z, Shao R, Li L, et al. Xuanfei Baidu decoction reduces acute lung injury by regulating infiltration of neutrophils and macrophages via PD-1\/IL17A pathway. Pharmacol Res. 2022;176:106083.","journal-title":"Pharmacol Res"},{"issue":"4","key":"1324_CR152","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1164\/rccm.202205-0860ED","volume":"206","author":"JK Narayana","year":"2022","unstructured":"Narayana JK, Tsaneva-Atanasova K, Chotirmall SH. Microbiomics-focused data integration: a fresh solve for the Rubik\u2019s Cube of endophenotyping? American J Respir Crit Care Med. 2022;206(4):365\u20138.","journal-title":"American J Respir Crit Care Med"},{"issue":"1","key":"1324_CR153","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12931-022-02254-9","volume":"23","author":"Y-H Gao","year":"2022","unstructured":"Gao Y-H, Lu H-W, Mao B, Guan W-J, Song Y-L, Li Y-Y, et al. The Establishment of China bronchiectasis registry and research collaboration (BE-China): protocol of a prospective multicenter observational study. Respir Res. 2022;23(1):328.","journal-title":"Respir Res"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01324-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01324-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01324-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T09:03:31Z","timestamp":1768381411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01324-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01324-0","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"5 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}